FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease
Authors:
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 48, 491-504
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81570746, 81770812)
This publication has 40 references indexed in Scilit:
- microRNA‐206 overexpression inhibits epithelial‐mesenchymal transition and glomerulosclerosis in rats with chronic kidney disease by inhibiting JAK/STAT signaling pathwayJournal of Cellular Biochemistry, 2019
- Valsartan inhibits amylin-induced podocyte damageMicrovascular Research, 2016
- Lentiviral Vector-Mediated FoxO1 Overexpression Inhibits Extracellular Matrix Protein Secretion Under High Glucose Conditions in Mesangial CellsJournal of Cellular Biochemistry, 2015
- Effects of FoxO1 on podocyte injury in diabetic ratsBiochemical and Biophysical Research Communications, 2015
- Therapeutic approaches to diabetic nephropathy—beyond the RASNature Reviews Nephrology, 2014
- STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signalingNature Immunology, 2014
- Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplayEMBO Molecular Medicine, 2013
- The JAK-STAT Pathway at TwentyImmunity, 2012
- The RAAS in the pathogenesis and treatment of diabetic nephropathyNature Reviews Nephrology, 2010
- The FoxO codeOncogene, 2008